loader
Please Wait
Applying Filters...
menu
    • menu

    Quality Alerts: Sanofi-Aventis Australia Recalling One Batch of Stemetil (prochlorperazine maleate) 5 mg Tablets - Sanofi

    MenuSanofi

    Uploaded: 2022
    News
    Sanofi CEO Garijo Aims To Reduce Dependence On Dupixent

    28 Apr 2026

    // BIOSPACE

    Sanofi has 'vigorous defense planned' for Dupixent patent cliff

    24 Apr 2026

    // FIERCE PHARMA

    Sanofi Prices $2.3B Bond Issue

    24 Apr 2026

    // GLOBENEWSWIRE

    DATA COMPILATION
    #PharmaFlow

    Sanofi 250

    Contact Supplier

    Website

    AMWC Asia-TDAC

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/m_Qi26UsERU
    Xls

    CATEGORY PAGE
    Menu

    Sanofi

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC107029
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.